Structure and activities of hospital drug committees in Germany

European Journal of Clinical Pharmacology

Volumn 52, Issue 6, 1997, Pages 429-435

  Thurmann P A ^a   Harder, S ^a   Steioff, A ^a  

^a Hospital Wuppertal GmbH   (Germany)

Author keywords

Clinical pharmacology; Hospitals drug committees; Rational pharmacotherapy

Indexed keywords

ARTICLE; DECISION MAKING; DRUG COST; DRUG FORMULARY; DRUG INFORMATION; DRUG THERAPY; DRUG USE; GERMANY; HOSPITAL PHARMACY; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE;

FORMULARIES, HOSPITAL; GERMANY; HOSPITAL ADMINISTRATION; HUMANS; PHARMACOLOGY, CLINICAL; PHARMACY AND THERAPEUTICS COMMITTEE; QUESTIONNAIRES;

EID: 0030821835     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050315     Document Type: Article

References (39)

1. Kehoe MJ (1970) The hospital formulary and the pharmacy and therapeutics committee. Hosp Formulary Manage 5: 9-11
2. Brown AW, Barrett CW, Herxheimer A (1975) Hospital pharmacy committees in England: their structure, function and development. BMJ I: 323-326
3. Kewitz H (1986) Arzneimittelliste für Krankenhäuser Wie entstehen sie und was nützen sie? Internist 27: 13-20
4. Summers KH, Szeinbach SL (1993) Formularies: the role of pharmacy-and-therapeutics (P&T) committees. Clin Ther 15: 433-441
5. Rucker TD (1988) Quality control of hospital formularies. Pharmaceutic Weekblad-Scientific Edition 10: 145-150
6. Baker JA, Lant AF, Sutters CA (1988) Seventeen years' experience of a voluntary based drug rationalisation programme in hospital. BMJ 297: 465-469
7. Hazlet TK, Hu TW (1992) Association between formulary strategies and hospital drug expenditures. Am J Hosp Pharm 49: 2207-2210
8. Jönsson B (1994) Drug formularies - good or evil? Discussion. Cardiology 85 [Suppl 1]: 54-56
9. Wade WE, Spruill WJ, Taylor AT, Longe RL, Hawkins DW (1996) The expanding role of pharmacy and therapeutics committees. Pharmaco Economics 10: 123-128
10. American Society of Hospital Pharmacists (1984) Statement on the pharmacy and therapeutics committee. Am J Hosp Pharm 41: 1621
11. Sutters CA (1990) The management of a hospital pharmacy. J Clin Pharm Ther 15: 59-76
12. Atkinson AJ Jr, Nordstrom K (1996) The challenge of inhospital medication use: an opportunity for clinical pharmacology. Clin Pharmacol Ther 60: 363-367
13. Rote Liste (1994) Bundesverband der Pharmazeutischen Industrie. Editio Cantor Verlag für Medizin und Naturwissenschaften. Aulendorf, Germany
14. Deutsches Krankenhausadressbuch (1995) Rombach GmbH Druck- und Verlagshaus, Freiburg im Breisgau, Germany
15. Harder S, Böger R, Bode-Böger S, Drewelow B, Krappweis J, Masschner JP, Molz KH, Plangger A, Szucs T, Tepper J, Theison U, Thürmann P. (study group "Pharmaco Economics and rational Pharmacotherapy", GK Pharm) (1994) Drug utilization review in German hospitals (abstract). Eur J Clin Pharmacol 47: A102
16. Schütte G (1987) Krankenhausapotheken-relevante Daten. Krankenhauspharmazie 8: 447-449
17. Hartmann F (1990) Arzneimittelkommission - Erfahrung an einem Universitätsklinikum. Internist 31: 475-480
18. Thürmann P, Harder S (1993) Determinants of hospital drug expenditures in western Europe. Pharmaco Economics 4: 157-161
19. Avorn J (1996) Drug use in academic medical centres in an era of ferment. Pharmaco Economics 10 [Suppl 2]: 124-129
20. Anonymus (1989) Potential conflict of interest of a pharmacy member and therapeutics committee member. Am J Hosp Pharm 46: 2047-2050
21. Grimm E, Haefeli WE, Schlienger R, Meier C, Surber C (1996) Problem-oriented drug information services: common requests during a 10 year experience (abstract). Eur J Clin Pharmacol 50: 526
22. Branch RA, Johnston PE, Koestner JA, Bluhm R, Stratton CW, Knight JR (1992) The formulary: an educational tool for clinical pharmacology. Clin Pharmacol Ther 51: 481-488
23. Öhman B, Lyrvall H, Törnqvist E, Alvan G, Sjöqvist F (1992) Clinical pharmacology and the provision of drug information. Eur J Clin Pharmacol 42: 563-568
24. Dollery C (1996) Clinical pharmacology: future prospects for the discipline. Br J Clin Pharmacol 42: 137-141
25. Collier J, Foster J (1985) Management of a restricted drugs policy in hospital: the first five years' experience. Lancet I: 331-333
26. Backe OM (1986) How many drugs do we need? World Health Forum 7: 252-255
27. Palm D (1987) Wieviele Beta-Rezeptoren-Blocker braucht der Arzt? Klin Wochenschr 65: 289-295
28. Anonymus (1989) Local drug formularies - are they worth the effort? Drug Ther Bull 27: 13-16
29. Segal R, Pathak S (1988) Formulary decision making: identifying factors that influence P&T Committee drug evaluations. Hosp Formulary 23: 174-178
30. Avorn J, Chen M, Hartley R (1982) Scientific versus commercial sources of influence on the prescribing behaviour of physicians. Am J Med 73: 4-8
31. Durand-Zaleski I, Bonnet F, Rochant H, Bierling P, Lemaire F (1992) Usefulness of consensus conferences: the case of albumin. Lancet 340: 1388-1390
32. Böger R, Bode-Böger S, Frölich JC (1995) Consensus conferences - impact on clinical prescribing. Int J Clin Pharmacol Ther 33: 471-472
33. Böger R, Bode-Böger S, Frölich JC (1995) Intravenöse Immunglobuline. Grundlagen, Auswahlkriterien und Indikationen für ihren prophylaktischen und therapeutischen Einsatz. Med Klinik 90: 520-526
34. Marschner J-P, Rietbrock N (1996) Therapieempfehlungen für den Einsatz intravenös anwendbarer Immunglobuline. Med Klinik 91: 141-147
35. Miyagawa C, Riviera JO (1986) Effect of pharmacist interventions on drug therapy costs in a surgical intensive-care unit. Am J Hosp Pharm 43: 3008-3013
36. Feely J, Chan R, Cocoman L, Mulpeter K, O'Connor P (1990) Hospital formularies: need for continuous intervention. BMJ 300: 28-30
37. Jay GT, Quercia RA, Gousse G, Chow MSS. Quintiliani R (1993) Procedure for evaluating nonformulary drug orders. Am J Hosp Pharm 50: 2554-2556
38. Hanish L (1993) Dealing with demands for nonformulary drugs. Am J Hosp Pharm 49: 2920-2923
39. Harder S, Thürmann P, Huber Th, Rietbrock N (1991) Prescription of drugs not listed in a clinic's pharmacopoeia: supervision by clinical pharmacologists. Eur J Clin Pharmacol 40: 561-564